This HTML5 document contains 224 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1093/NEUONC/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q53829808
rdf:type
wikibase:Item
schema:description
vědecký článek wetenschappelijk artikel article scientifique (publié 2018) 2018年學術文章 2018년 논문 επιστημονικό άρθρο teaduslik artikkel artigo científico artículo científico publicado en 2018 מאמר מדעי 2018年の論文 مقالهٔ علمی 2018 ഏപ്രില്‍ 5 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം 2018年学术文章 научни чланак 2018年學術文章 scienca artikolo articolo scientifico wissenschaftlicher Artikel vitskapeleg artikkel наукова стаття, опублікована у квітні 2018 2018年学术文章 2018年學術文章 vedecký článok artikulong pang-agham artykuł naukowy vitenskapelig artikkel vetenskaplig artikel 2018年學術文章 article scientific мақолаи илмӣ научная статья videnskabelig artikel (udgivet 2018) artigo científico (publicado na 2018) мақолаи илмӣ artículu científicu mokslinis straipsnis 2018年学术文章 naučni članak artigo científico (publicado na 2018) مقالة علمية 2018年学术文章 سائنسی مضمون article científic tudományos cikk 2018年学术文章 2018年學術文章 2018年學術文章 artikull shkencor scientific article tieteellinen artikkeli ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2018 nî lūn-bûn գիտական հոդված บทความทางวิทยาศาสตร์ научна статия articol științific bài báo khoa học научни чланак bilimsel makale სამეცნიერო სტატია
p:P577
wds:Q53829808-DEC9C67A-6A82-45BF-A9F4-F2FE71AD7C26
wdt:P577
2018-04-05T00:00:00Z
p:P2860
wds:Q53829808-07654913-96A5-4E46-B80F-C155EED5423A wds:Q53829808-0F6F673A-FFF5-4A69-8E86-77D22AF1B38D wds:Q53829808-14115537-7E29-45E9-B4D4-780DD1A6FD5F wds:Q53829808-0A054774-E01D-4CAB-87FE-2509BB27A8E0 wds:Q53829808-0C767138-8416-491F-BA0B-5C7D45FCC002 wds:Q53829808-0D4D3CB6-4E96-494C-9CDE-F9931BCB1B31 wds:Q53829808-0E4EDE28-1C6E-48AA-B64C-84B49AB87FEA wds:Q53829808-27321C6D-AC08-4C41-87D4-BEC65ABC9940 wds:Q53829808-3FBCA0EB-FB3D-42AC-8955-B076273011D1 wds:Q53829808-3FF50D3D-83AA-4D8B-8395-ACE7877C0CFD wds:Q53829808-21A76B56-2A45-4C15-9ED3-6EB57BF042FF wds:Q53829808-255E9044-B1B4-460B-B5D3-BB235F654301 wds:Q53829808-268FE005-16F1-4EE9-8B16-186EBA564B35 wds:Q53829808-59D0AADD-7344-4CEF-A3DB-9EE5D5B0E7D9 wds:Q53829808-4FC64601-00EB-4C66-8530-1104DE65E19A wds:Q53829808-53EAC768-A71F-4DA7-A557-54AD8536F221 wds:Q53829808-71AEA619-EF67-45ED-910E-093A26B60684 wds:Q53829808-7696B9B4-4E13-4018-AE5C-E316F186D8B1 wds:Q53829808-662663C6-C6B9-409B-A640-7F87265C6907 wds:Q53829808-6B1C2F95-82D7-4C0C-A83A-5A346ED75FB7 wds:Q53829808-88BD2FB9-4B1F-493A-9951-D4BBCC797007 wds:Q53829808-8DE3DCE4-A4AF-413A-9004-E8655ECA42A7 wds:Q53829808-76FF9B9C-B984-4FDA-8E83-D1D2B0316BD9 wds:Q53829808-7A331AA4-6631-43BF-ADFE-D2347341E7B7 wds:Q53829808-859393C2-3568-4238-83FD-53B5C31A2C6D wds:Q53829808-9E5E9412-E1A2-4956-8A3D-FA63FFB976A9 wds:Q53829808-A543375B-0CDC-4668-9D49-B2171F432085 wds:Q53829808-A5CD682D-A83C-4576-A4F9-8394D4FE9227 wds:Q53829808-9003EFF2-7E20-41BA-8A7A-DFEA8F54C121 wds:Q53829808-921F6E54-721E-4F17-A5B9-050931212676 wds:Q53829808-9ACAF3C4-79FA-4306-88CB-C306A8CA5B9A wds:Q53829808-9E528FE0-AB8A-4189-B65C-A8C5DD22FC0B wds:Q53829808-B52C42CA-48A9-4DFA-A453-C6355A3E722A wds:Q53829808-B91A946B-2AEE-4CAE-AC54-EC45E455ABC8 wds:Q53829808-A9F76530-DEF4-4F1A-89B7-42DA1E91AFCF wds:Q53829808-B033AF60-C472-4FA7-ACC9-0162D57D7F63 wds:Q53829808-B44EF21B-691E-4C8D-9FF2-3DC657729FAD wds:Q53829808-CF2BBC6B-1635-41AF-83FE-A1B8FA89754E wds:Q53829808-D4C51772-B377-4022-A735-6CB23331BE96 wds:Q53829808-BD83702E-4C0C-4B46-9B73-4BD3A52962C9 wds:Q53829808-C95C6EA1-A387-4BB5-AD5F-6E301B6B87A6 wds:Q53829808-E5D38725-026D-439C-8A03-7EC0726F9A90 wds:Q53829808-D99784BF-DD81-415C-94A9-F3C37C0C6B56 wds:Q53829808-E341875E-A59B-45FF-B6BB-11EBFF71AC78 wds:Q53829808-E4C104A0-E08C-40CC-A18B-FEDC4869BFB3 wds:Q53829808-FD4CA6D9-636D-48A8-BDB2-7AE35899B679 wds:Q53829808-FF5C4A9E-0BEF-4869-AE39-5543B9B50D1C wds:Q53829808-FFD0FE09-007A-4C27-8F3F-5275EBC3C0B0
wdt:P2860
wd:Q34495684 wd:Q39684120 wd:Q36822111 wd:Q39435280 wd:Q37148350 wd:Q24683896 wd:Q27860910 wd:Q37672654 wd:Q33373988 wd:Q46170165 wd:Q47399678 wd:Q33946929 wd:Q34185084 wd:Q48207492 wd:Q44421351 wd:Q46942082 wd:Q33382596 wd:Q31148416 wd:Q38958800 wd:Q74329870 wd:Q28487568 wd:Q29617568 wd:Q48585558 wd:Q45069709 wd:Q30444953 wd:Q36103026 wd:Q48264845 wd:Q38835745 wd:Q30490422 wd:Q35111750 wd:Q35800552 wd:Q45070195 wd:Q74628193 wd:Q30744946 wd:Q36962825 wd:Q24293027 wd:Q39472261 wd:Q46825520 wd:Q35112894 wd:Q55470198 wd:Q44393459 wd:Q33416502 wd:Q24546291 wd:Q29547224 wd:Q33667156 wd:Q30427255 wd:Q46712950 wd:Q39212474
p:P2093
wds:Q53829808-1C5EE003-7D53-4472-A64A-8586784B0641 wds:Q53829808-BDBFEA3B-9110-4B75-97EB-1C440A101B17 wds:Q53829808-FBFC056A-40F1-477C-A54A-9EF3E1A0D6B0 wds:Q53829808-A8C19C7C-321C-42B6-97A7-CE5CDC7789B1 wds:Q53829808-BD762BEE-582D-4C7B-ABCB-F3206F620A0E wds:Q53829808-685ED2D4-995C-4E49-915C-E8E4D763755A wds:Q53829808-6C4AFDC0-B29A-4ACD-9421-CE13BA616940 wds:Q53829808-87D84DCF-369E-46C1-BA3F-8F8CEE8B6418 wds:Q53829808-1D8A6FA4-03A4-4AD6-92E6-76D076691EFC wds:Q53829808-6309DF59-DC40-41BE-88DD-372853E68FF7
wdt:P2093
Davis C Woodworth Dana T Aftab Ararat Chakhoyan Gisela M Schwab Catalina Raymond John de Groot Robert J Harris Colin Hessel David Schiff Kevin Leu
rdfs:label
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma. Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.
skos:prefLabel
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma. Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.
schema:name
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma. Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.
p:P50
wds:Q53829808-EAAAEC42-ABC2-475F-8A7D-F80F13438CB4 wds:Q53829808-FC115282-FC0E-4EA4-B72C-1B853DDAFE53 wds:Q53829808-CA19F8FC-1B32-4A68-9AFB-AF7121E227D2 wds:Q53829808-4850628E-A3B7-403E-AF84-B8C190E39A80 wds:Q53829808-55D72408-863E-4700-8C25-BC50DFA61574 wds:Q53829808-5A516EC9-03EF-4779-86C9-30578545EAC1 wds:Q53829808-5EEE9F32-A36D-4A06-997B-64B4A76C0C7A wds:Q53829808-316B8FD5-CCDD-4000-9029-08B8AD6156F9 wds:Q53829808-BC232373-0B7D-486D-9DD0-564B8254484C wds:Q53829808-83161B72-24DB-49A4-944F-736A55E26FC8 wds:Q53829808-8C895990-E290-4A62-8B50-2320002CC5ED wds:Q53829808-66B3241A-7288-4A25-9988-304CDC202F78
wdt:P50
wd:Q73536038 wd:Q47159504 wd:Q117261474 wd:Q73570385 wd:Q117261473 wd:Q47159896 wd:Q90068261 wd:Q117261475 wd:Q55459098 wd:Q105531697 wd:Q114338680 wd:Q88054225
p:P1476
wds:Q53829808-05D9B5B0-535F-4DDE-9EB0-68FDBEAD0D1A
wdt:P1476
Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma.
p:P31
wds:Q53829808-A46987EF-CC9A-4023-8CC6-E11833EBBFFC
wdt:P31
wd:Q13442814
p:P698
wds:Q53829808-74EB711D-572E-44B5-B342-B97E9FE4F5E9
wdtn:P698
n10:29660005
wdt:P698
29660005
p:P1433
wds:Q53829808-C157A6A5-F3BF-4ACA-8188-E59E2D20C494
wdt:P1433
wd:Q15724471
p:P356
wds:Q53829808-13D69A2B-0727-4D0A-95F5-724E0BACF4CC
wdtn:P356
n12:NOY054
wdt:P356
10.1093/NEUONC/NOY054
p:P932
wds:Q53829808-D1E275D8-1DBA-4673-8F24-7B3F3EF95CAD
wdt:P932
6120362